The ACOX1 gene plays a critical role in the metabolism of fatty acids within the peroxisomes, a specialized compartment in the cell. Mutations in the ACOX1 gene can lead to a rare metabolic disorder known as Acyl-CoA Oxidase Deficiency. This condition disrupts the normal breakdown of long-chain fatty acids, leading to a buildup of toxic substances in the body, which can result in severe neurological and developmental issues.
To diagnose this condition, a genetic test targeting the ACOX1 gene can be conducted. DNA Labs UAE offers this specific test, providing a reliable means of diagnosing Acyl-CoA Oxidase Deficiency. The test involves analyzing the patient's DNA to identify mutations in the ACOX1 gene that are indicative of the disorder.
The cost of the ACOX1 Gene Acyl-CoA Peroxisomal Oxidase Deficiency Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the specialized nature of the test, the advanced technology used in the analysis, and the professional expertise required to interpret the results accurately. Once the test is conducted, healthcare providers can use the results to confirm a diagnosis, which is crucial for developing an effective treatment plan and managing the condition.
The ABCD1 Gene Adrenoleukodystrophy (ALD) X-Linked Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the ABCD1 gene, which are responsible for X-linked adrenoleukodystrophy. This genetic disorder affects the nervous system and adrenal glands, leading to a wide range of symptoms from difficulty in concentrating to severe physical disabilities. The test is particularly crucial for early detection and management of the condition, as well as for family planning purposes for those with a history of ALD. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, this test provides a comprehensive analysis of the ABCD1 gene to identify any aberrations. The cost of the test is 3200 AED, an investment towards understanding one's genetic health and taking proactive steps in managing the condition effectively.
The PLXNB3 Gene Adrenoleukodystrophy (ALD) X-linked Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the PLXNB3 gene that are associated with X-linked Adrenoleukodystrophy, a genetic disorder. This condition affects the nervous system and the adrenal glands, leading to a wide range of symptoms, including behavioral changes, loss of function in the adrenal gland, and progressive neurological decline. The test is crucial for early detection and management of the disorder, particularly in families with a history of ALD. Priced at 3200 AED, the test involves analyzing the patient's DNA to detect mutations in the PLXNB3 gene, providing essential information for diagnosis, treatment planning, and genetic counseling. DNA Labs UAE ensures a comprehensive and reliable testing process, employing advanced genetic testing technologies to assist patients and their families in managing this challenging condition.
The ABCD1 Gene Adrenoleukodystrophy/Adrenomyeloneuropathy Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to detect mutations in the ABCD1 gene. These mutations are responsible for a range of genetic disorders, including Adrenoleukodystrophy (ALD) and Adrenomyeloneuropathy (AMN), which are X-linked conditions affecting the nervous system and adrenal glands. The test, priced at 4400 AED, involves analyzing the patient's DNA to identify any abnormalities in the ABCD1 gene that could lead to these conditions. This test is crucial for early detection and management of ALD and AMN, potentially guiding treatment options and family planning decisions. DNA Labs UAE employs advanced genetic testing technologies to ensure accurate and reliable results, offering a critical resource for individuals and families at risk of these genetic disorders.
The SLC12A6 gene plays a crucial role in the development and function of the nervous system. Mutations in this gene can lead to a rare genetic disorder known as Agenesis of the Corpus Callosum with Peripheral Neuropathy (ACCPN). This condition is characterized by the absence or underdevelopment of the corpus callosum, the part of the brain that connects the two cerebral hemispheres, along with peripheral neuropathy, which affects the peripheral nerves.
To diagnose this condition, a genetic test focusing on the SLC12A6 gene can be conducted. DNA Labs UAE offers this specific genetic test to identify mutations in the SLC12A6 gene that are indicative of ACCPN. The test is crucial for accurate diagnosis and can aid in the management and treatment of the condition.
The cost of the SLC12A6 gene genetic test at DNA Labs UAE is 3200 AED. This test is a vital tool for families and individuals at risk of ACCPN, providing them with essential information for healthcare planning and intervention.
The TREX1 gene Aicardi-Goutieres syndrome type 1 genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the TREX1 gene, which are associated with Aicardi-Goutieres syndrome type 1 (AGS1). Aicardi-Goutieres syndrome is a rare genetic disorder that affects the brain, the immune system, and the skin. It is characterized by early-onset encephalopathy, leading to severe mental and physical developmental issues, along with skin lesions and other systemic symptoms.
The test aims to provide crucial information for the diagnosis and management of AGS1, facilitating early intervention strategies and personalized care plans for affected individuals. It involves the collection of a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the state-of-the-art facilities at DNA Labs UAE. The laboratory utilizes advanced genetic sequencing techniques to detect the presence of mutations in the TREX1 gene, which is pivotal for confirming the diagnosis of AGS1.
The cost of the TREX1 gene Aicardi-Goutieres syndrome type 1 genetic test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the test, covering the expenses associated with the sophisticated technology and expert analysis required to accurately identify mutations in the TREX1 gene. For families and individuals facing the possibility of AGS1, this test represents a critical step towards understanding their condition and accessing the appropriate medical and support services.
The RNASEH2B gene plays a crucial role in the maintenance and integrity of DNA. Mutations in this gene are associated with Aicardi-Goutieres syndrome type 2, a rare genetic disorder characterized by early-onset encephalopathy, leading to severe physical and intellectual disabilities. The syndrome mimics congenital viral infections and triggers an abnormal immune response, causing inflammation in the brain.
To diagnose this condition, a genetic test focusing on the RNASEH2B gene is available at DNA Labs UAE. This test is designed to identify mutations in the RNASEH2B gene that are indicative of Aicardi-Goutieres syndrome type 2. Early diagnosis through genetic testing is vital for the management of the syndrome, allowing for appropriate interventions and supportive care to be initiated promptly.
The cost of the RNASEH2B Gene Aicardi-Goutieres syndrome type 2 genetic test at DNA Labs UAE is 4400 AED. This investment can be crucial for families seeking answers to unexplained symptoms of encephalopathy and other related manifestations in their children. The test provides a definitive diagnosis, enabling affected families to access the necessary medical and support services, and to better understand the condition's implications.
The RNASEH2C gene plays a critical role in the development of Aicardi-Goutieres syndrome type 3, a rare genetic disorder characterized by neurological and immunological abnormalities. Aicardi-Goutieres syndrome can mimic congenital viral infections and leads to a range of symptoms, including developmental delay, microcephaly, and skin lesions, among others. It is an autosomal recessive condition, meaning that an affected individual inherits two defective copies of the gene, one from each parent.
Genetic testing for mutations in the RNASEH2C gene is essential for the accurate diagnosis of Aicardi-Goutieres syndrome type 3. This test involves analyzing the DNA to identify mutations in the RNASEH2C gene that are known to cause the disorder. Early diagnosis through genetic testing can aid in the management of the condition and help inform family planning decisions.
In the UAE, this specific genetic test is available at DNA Labs UAE, a reputable facility known for its comprehensive range of genetic testing services. The cost of the RNASEH2C gene test for Aicardi-Goutieres syndrome type 3 is 4400 AED. This test is crucial for families with a history of the syndrome or who have children showing symptoms indicative of the condition. By opting for this test, parents can gain valuable insights into their child's health and make informed decisions about their care and treatment options.
The RNASEH2A gene is associated with Aicardi-Goutieres syndrome type 4 (AGS4), a rare genetic disorder that typically presents in infancy with severe neurological symptoms, including developmental delay, spasticity, and encephalopathy. AGS mimics congenital viral infections and is characterized by an overactive immune response in the brain. The RNASEH2A gene plays a crucial role in DNA repair and the maintenance of genome stability. Mutations in this gene disrupt these processes, leading to the accumulation of DNA fragments in the cell, triggering an abnormal immune response.
A genetic test for the RNASEH2A gene can confirm a diagnosis of Aicardi-Goutieres syndrome type 4. This test is particularly useful for families with a history of the condition or when a child presents with symptoms suggestive of AGS4. The test involves analyzing the patient's DNA, extracted from a blood sample, for mutations in the RNASEH2A gene that are known to cause the disorder.
In the UAE, this specific genetic test is available at DNA Labs UAE, a leading provider of genetic testing and analysis services. The cost of the RNASEH2A gene test for Aicardi-Goutieres syndrome type 4 is 4400 AED. This comprehensive test not only aids in the diagnosis of AGS4 but also helps in the management and treatment planning for affected individuals. It can also provide valuable information for family planning to at-risk couples.
The SAMHD1 gene plays a critical role in the human body's immune response and cell cycle regulation. Mutations in this gene are associated with Aicardi-Goutières syndrome type 5 (AGS5), a rare genetic disorder that affects the brain, immune system, and skin. This condition is characterized by early-onset encephalopathy, which presents with severe intellectual disability, loss of motor control, and seizures, alongside symptoms like skin rashes and an increased susceptibility to autoimmune conditions.
To diagnose AGS5, genetic testing of the SAMHD1 gene is essential. DNA Labs UAE offers a comprehensive genetic test for this purpose, enabling precise identification of mutations in the SAMHD1 gene. The test is crucial for confirming the diagnosis of AGS5, understanding the genetic basis of the condition, and facilitating genetic counseling for affected families.
The cost of the SAMHD1 Gene Aicardi-Goutières syndrome type 5 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the detailed analysis necessary to detect the specific mutations in the SAMHD1 gene that are responsible for AGS5. Early and accurate diagnosis through this test can significantly impact the management and treatment options for individuals with this syndrome, providing them with a better quality of life.
